Business
Resignation of John Lidgey
Resignation of John Lidgey.
About this update from Nuformix Plc
[{"type":"text","content":"\n \nRNS Number : 9772A Nuformix PLC 27 January 2020 \n\n27 January 2020\nNuformix plc\n(\"Nuformix\" or \"the Group\"),\n \nResignation of John Lidgey\n \nNuformix, the pharmaceutical development company using cocrystal technology to unlock the therapeutic potential of approved small molecule drugs announces the resignation of John Lidgey from the Nuformix Board of Directors with effect on 31 January 2020. John chaired Levrett plc from inception through to the successful reverse merger with Nuformix in October 2017 and then remained on the Board as NED. He has now decided it is time to move on to pursue new opportunities.\n \nDr Dave Tapolczay, Chairman, Nuformix plc, said: \"On behalf of the Board and the Company, I would like to sincerely thank John for his work and commitment to the Board and the Company during his tenure, a period of accomplishment as Nuformix has established itself post the reverse merger with Levrett plc. The Board would like to wish John well in his future endeavours. John's departure creates an opportunity to bring new specialist life sciences experience to the Board, at a time when Nuformix faces exciting opportunities to continue it's trajectory of progress and we look forward to updating shareholders on developments with both the Company and the Board in the near future\"\n \nMarket Abuse Regulation (MAR) Disclosure. Certain information contained in this announcement would have been deemed inside information for the purposes of Article 7 of Regulation (EU) No 596/2014 until the publication of this announcement via a Regulatory Information Service and accordingly, this inside information is now considered to be in the public domain.\n \nEnquiries:\n \n\n\n\nNuformix plc\nDr Dan Gooding, Chief Executive Officer\nEmail: [email protected]\n \n\n\n \n \n+44 (0)1223 627222\n \n\n\n\n\n \nNovum Securities Limited\nJon Belliss / Colin Rowbury \n\n\n \n \n+44 (0)20 7399 9427\n\n\n\n \n \nAbout Nuformix plc www.nuformix.com \nNuformix is a pharmaceutical development company using cocrystal technology to unlock the therapeutic potential of approved small molecule drugs. Nuformix's risk-mitigated development strategy has resulted in a pipeline of discoveries through which it...